Treatment of levodopa‐induced motor complications
Identifieur interne : 000632 ( Main/Curation ); précédent : 000631; suivant : 000633Treatment of levodopa‐induced motor complications
Auteurs : Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2008.
English descriptors
Abstract
Chronic levodopa treatment for Parkinson's disease patients is frequently associated with the development of motor complications such as end‐of‐dose wearing‐off and dyskinesias. In this review, we provide an overview of the strategies available for dealing with these problems. Medical management includes manipulation of levodopa dosing to establish the optimum treatment schedule, improving levodopa absorption, catechol‐O‐methyl transferase‐inhibition (COMT), Monoamine oxidase‐B (MAO‐B) inhibition, dopaminergic agonists, amantadine, and continuous dopaminergic infusions. Surgical procedures and particularly deep brain stimulation are also reviewed. It should be noted that none of these treatments has been shown to provide anti‐parkinsonian efficacy that is greater than what can be achieved with levodopa. We highlight the importance of initiating therapy with a treatment strategy that reduces the risk that a Parkinson's disease patient will develop motor complications in the first place. Key Words: Advanced PD, dyskinesias, motor fluctuations, levodopa, dopamine agonists, COMT inhibitors, MAO‐B inhibitors. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22052
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000723
Links to Exploration step
ISTEX:FB819C4FEC283B3BB9A75DE1B178F8C4EF044955Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of levodopa‐induced motor complications</title>
<author><name sortKey="Stocchi, Fabrizio" sort="Stocchi, Fabrizio" uniqKey="Stocchi F" first="Fabrizio" last="Stocchi">Fabrizio Stocchi</name>
<affiliation wicri:level="1"><mods:affiliation>IRCCS San Raffaele, Via della Pisana 235, Roma, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>IRCCS San Raffaele, Via della Pisana 235, Roma</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tagliati, Michele" sort="Tagliati, Michele" uniqKey="Tagliati M" first="Michele" last="Tagliati">Michele Tagliati</name>
<affiliation wicri:level="1"><mods:affiliation>Mount Sinai School of Medicine, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="1"><mods:affiliation>Mount Sinai School of Medicine, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FB819C4FEC283B3BB9A75DE1B178F8C4EF044955</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22052</idno>
<idno type="url">https://api.istex.fr/document/FB819C4FEC283B3BB9A75DE1B178F8C4EF044955/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000723</idno>
<idno type="wicri:Area/Main/Curation">000632</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of levodopa‐induced motor complications</title>
<author><name sortKey="Stocchi, Fabrizio" sort="Stocchi, Fabrizio" uniqKey="Stocchi F" first="Fabrizio" last="Stocchi">Fabrizio Stocchi</name>
<affiliation wicri:level="1"><mods:affiliation>IRCCS San Raffaele, Via della Pisana 235, Roma, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>IRCCS San Raffaele, Via della Pisana 235, Roma</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tagliati, Michele" sort="Tagliati, Michele" uniqKey="Tagliati M" first="Michele" last="Tagliati">Michele Tagliati</name>
<affiliation wicri:level="1"><mods:affiliation>Mount Sinai School of Medicine, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="1"><mods:affiliation>Mount Sinai School of Medicine, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008">2008</date>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">S3</biblScope>
<biblScope unit="supplement">S3</biblScope>
<biblScope unit="page" from="S599">S599</biblScope>
<biblScope unit="page" to="S612">S612</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">FB819C4FEC283B3BB9A75DE1B178F8C4EF044955</idno>
<idno type="DOI">10.1002/mds.22052</idno>
<idno type="ArticleID">MDS22052</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>advanced Parkinson's disease</term>
<term>dopamine agonists</term>
<term>dyskinesias</term>
<term>levodopa</term>
<term>motor fluctuations</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chronic levodopa treatment for Parkinson's disease patients is frequently associated with the development of motor complications such as end‐of‐dose wearing‐off and dyskinesias. In this review, we provide an overview of the strategies available for dealing with these problems. Medical management includes manipulation of levodopa dosing to establish the optimum treatment schedule, improving levodopa absorption, catechol‐O‐methyl transferase‐inhibition (COMT), Monoamine oxidase‐B (MAO‐B) inhibition, dopaminergic agonists, amantadine, and continuous dopaminergic infusions. Surgical procedures and particularly deep brain stimulation are also reviewed. It should be noted that none of these treatments has been shown to provide anti‐parkinsonian efficacy that is greater than what can be achieved with levodopa. We highlight the importance of initiating therapy with a treatment strategy that reduces the risk that a Parkinson's disease patient will develop motor complications in the first place. Key Words: Advanced PD, dyskinesias, motor fluctuations, levodopa, dopamine agonists, COMT inhibitors, MAO‐B inhibitors. © 2008 Movement Disorder Society</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000632 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000632 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:FB819C4FEC283B3BB9A75DE1B178F8C4EF044955 |texte= Treatment of levodopa‐induced motor complications }}
This area was generated with Dilib version V0.6.23. |